Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
Images in Dermatology
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Media and news
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Images
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Reviewers 2022
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Snippets
Special Article
Specialty Interface
Studies
Study Letter
Study Letters
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
Therapy Letters
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Case Letter
ARTICLE IN PRESS
doi:
10.25259/IJDVL_1252_2023

Rituximab in the treatment of severe childhood pemphigus vulgaris accompanying phenylketonuria: A case report

Department of Dermatology, Dokuz Eylul University, Izmir, Turkey
Paediatric Metabolism Clinic, Dokuz Eylul University, Izmir, Turkey.

Corresponding author: Dr. Gülfem Akin, Department of Dermatology, Dokuz Eylul University, Izmir, Turkey. glfmakin@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Avcı C, Akin G, Aydogan A, Akarsu S, Ilknur T, Aktan S. Successful use of rituximab in the treatment of severe childhood pemphigus accompanying phenylketonuria: A case report. Indian J Dermatol Venereol Leprol. doi: 10.25259/IJDVL_1252_2023

Dear Editor,

Childhood pemphigus vulgaris is a pediatric variant of pemphigus vulgaris characterised by skin and mucous membrane blisters and erosions.1 Managing protein loss can be challenging in pemphigus vulgaris patients associated with phenylketonuria (PKU). Here, we describe a 10-year-old girl with phenylketonuria (PKU) and severe childhood pemphigus vulgaris who did not respond to high-dose corticosteroids and intravenous immunoglobulin (IVIG) but improved after rituximab infusion.

This child presented with generalised blisters, erosions, conjunctivitis, and oral lesions that persisted for 5 months. She was on a phenylalanine-restricted diet and used sapropterin dihydrochloride to lower phenylalanine levels.

Physical examination revealed flaccid blisters and extensive erosions on her trunk and extremities, covering approximately 45% of her body surface area [Figures 1a and 1b]. Her oral intake was limited due to painful oral mucosal involvement. The Pemphigus Disease Area Index (PDAI) activity score was 168. Laboratory tests showed mild anaemia (11.2 g/dL), eosinophilia (0.7x103/µL), thrombocytosis (513x103/µL), hypoalbuminemia (2.2 g/dL) and elevation in C-reactive protein (24.4 mg/dL; normal range: 0.2–5).

Extensive erosions on posterior trunk and lower extremities.
Figure 1a:
Extensive erosions on posterior trunk and lower extremities.
Erosions covered by haemorrhagic crusts on lips and periorbital areas.
Figure 1b:
Erosions covered by haemorrhagic crusts on lips and periorbital areas.

Skin biopsy specimens revealed suprabasal acantholysis [Figure 2] and direct immunofluorescence demonstrated intercellular deposition of IgG in the epidermis. Enzyme‐linked immunosorbent assay showed anti-BP180 negative, anti-BP230 2.11 ratio (>1 positive), anti-collagen tip VII negative, anti-Dsg1 negative, anti-Dsg3 10.09 ratio (>1 positive), and anti-envoplakin 1.94 ratio (>1 positive). Due to clinical severity and positive serological markers, malignancy screening was conducted to rule out paraneoplastic pemphigus. Tests included occult blood in faeces, peripheral smear, and protein electrophoresis. Imaging studies (chest X-ray, ultrasound for lymph nodes, abdominopelvic ultrasound, CT scans) showed no signs of solid tumours, hepatosplenomegaly or lymphadenopathy, nor atypical cells in peripheral blood smear.

Suprabasal acantholysis with a row of tombstones (Haemotoxylin and Eosin, 40x)
Figure 2:
Suprabasal acantholysis with a row of tombstones (Haemotoxylin and Eosin, 40x)

After confirming the diagnosis, systemic prednisone (1 mg/kg/day) was initiated but yielded no response. Prednisone dosage was increased to 1.5 mg/kg/day, with monthly IVIG (2 g/kg). Due to limited oral intake and protein loss causing hypoalbuminemia, protein intake was raised to 55 g/day, with weekly blood phenylalanine monitoring. Serum albumin below 2 g/dL prompted two albumin infusions at 3-week intervals. Weekly blood phenylalanine levels ranged from 10 to 15 mg/dL initially, maintained at 6–8 mg/dL over 1 year.

Despite 1 month of systemic corticosteroid therapy and two IVIG treatments, she showed no response, prompting rituximab administration (300 mg weekly for 4 weeks). Prednisolone was continued at 1.5 mg/kg/day, with a third round of IVIG. Tubular proteinuria after further IVIG led to its discontinuation. Lesions began to re-epithelise after the second rituximab infusion, with no new blisters. However, after the fourth infusion, she developed COVID-19 and recovered with supportive care. Prednisolone was gradually tapered by 5 mg monthly, but oral lesions remained resistant. Six months post-rituximab, a relapse occurred, necessitating a maintenance infusion (500 mg, iv). She has been in remission for the past 7 months [Figures 3a and 3b].

Resolution of skin lesions at 12 months post-treatment.
Figure 3a:
Resolution of skin lesions at 12 months post-treatment.
Resolution of skin lesions at 12 months post-treatment.
Figure 3b:
Resolution of skin lesions at 12 months post-treatment.

Antibodies against BP230 and envoplakin, proteins of the plakin family, are typically found in paraneoplastic pemphigus patients.2 However, cases of pemphigus vegetans with periplakin antibodies and pemphigus vulgaris with anti-desmoplakin antibodies have been reported.3,4 Despite this, no underlying malignancy was detected. In our patient, initial tissue damage from anti-desmoglein 3 may have led to an epitope-spreading phenomenon, resulting in antibodies against plakin family proteins.

While PKU is associated with various autoimmune disorders, childhood pemphigus vulgaris has not been reported.5 The coexistence of pemphigus vulgaris and PKU may reflect the susceptibility of PKU patients to autoimmune diseases.

Maintaining protein balance in severe childhood pemphigus vulgaris patients on a phenylalanine-restricted diet is challenging. Protein loss from skin lesions can lead to electrolyte imbalance and hypovolemic shock. To maintain the patient’s albumin level in balance, it is suggested to measure the albumin level closely and, if necessary, replace albumin and increase daily protein intake under weekly blood phenylalanine level monitoring.

Systemic corticosteroids are the mainstay of treatment in childhood pemphigus vulgaris in conjunction with steroid-sparing agents.6 Steroid-related side effects limit its long-term use in childhood.1 Some cases may be refractory, requiring additional therapies. Long-term follow-up is crucial due to relapses.6

Rituximab, recommended alongside systemic prednisolone for moderate-to-severe adult pemphigus vulgaris, shows growing evidence of safety and efficacy in childhood pemphigus vulgaris, despite limited data on its use in this population.1,6

Despite concerns about immunosuppression during the COVID-19 pandemic, rituximab was deemed necessary due to the severe and refractory nature of the patient’s pemphigus.

Except for one patient with phenylketonuria and pemphigus foliaceus reported by Scheinfeld, to our knowledge, PKU with childhood pemphigus vulgaris has not been reported in the literature.7 The management of protein deficiency and the efficacy of rituximab in a severe childhood pemphigus vulgaris case resistant to conventional corticosteroid treatment during the pandemic is highlighted in this case report.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

References

  1. , , , , , . Pediatric autoimmune blistering disorders – A five-year demographic profile and therapy experience. Int J Dermatol. 2022;61:1511-18.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , , , . Paraneoplastic pemphigus: A clinical, laboratorial, and therapeutic overview. An Bras Dermatol. 2019;94:388-98.
    [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
  3. , , , , , , et al. Pemphigus vegetans Neumann type with anti-desmoglein and anti-periplakin autoantibodies. Eur J Dermatol. 2007;17:530-3.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , , , et al. Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies. J Am Acad Dermatol. 2004;51:62-7.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , , , , et al. The challenges of managing coexistent disorders with phenylketonuria: 30 cases. Mol Genet Metab. 2015;116:242-51.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , , , , . Successful use of rituximab in the treatment of childhood and juvenile pemphigus. J Am Acad Dermatol. 2014;71:669-75.
    [CrossRef] [PubMed] [Google Scholar]
  7. . A case of co-incident phenylketonuria, pemphigus foliaceus, and tinea amiantacea treated with tetracycline and nicotinamide. J Drugs Dermatol. 2003;2:202-5.
    [PubMed] [Google Scholar]

Fulltext Views
1,438

PDF downloads
158
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections